Viking Therapeutics
Develops clinical-stage therapies for obesity, metabolic and endocrine disorders.
$32.24
After-hours close+0.10 (+0.31%)
At close$32.14(−5.08%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | −$1.07 | — | — |
| Jul 2026 | −$1.23 | −$1.10 | +10.6% |
| Apr 2026 | −$1.01 | −$1.37 | −35.6% |
| Feb 2026 | −$0.89 | −$1.38 | −55.1% |
| Oct 2025 | −$0.70 | −$0.81 | −15.7% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Oct 28, 2026 | −$1.07 | — | — | — | — | — |
| Jul 29, 2026 | −$1.23 | −$1.10 | +10.6% | — | — | — |
| Apr 29, 2026 | −$1.01 | −$1.37 | −35.6% | — | — | — |
| Feb 11, 2026 | −$0.89 | −$1.38 | −55.1% | $1.9M | — | — |
| Oct 22, 2025 | −$0.70 | −$0.81 | −15.7% | — | — | — |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Jul 23, 2025 | ||||||
| Apr 23, 2025 | ||||||
| Feb 5, 2025 | ||||||
| Oct 23, 2024 | ||||||
| Jul 24, 2024 | ||||||
| Apr 24, 2024 | ||||||
| Feb 7, 2024 | ||||||
| Oct 25, 2023 | ||||||
| Jul 26, 2023 | ||||||
| Apr 26, 2023 | ||||||
| Feb 8, 2023 | ||||||
| Oct 26, 2022 | ||||||
| Jul 27, 2022 | ||||||
| Apr 27, 2022 | ||||||
| Feb 9, 2022 | ||||||
| Nov 3, 2021 | ||||||
| Jul 28, 2021 | ||||||
| Apr 28, 2021 | ||||||
| Feb 17, 2021 | ||||||
| Oct 28, 2020 | ||||||
| Jul 29, 2020 | ||||||
| Apr 30, 2020 | ||||||
| Feb 26, 2020 | ||||||
| Nov 5, 2019 | ||||||
| Aug 1, 2019 | ||||||
| May 2, 2019 | ||||||
| Mar 13, 2019 | ||||||
| Nov 7, 2018 | ||||||
| Aug 9, 2018 | ||||||
| May 9, 2018 | ||||||
| Mar 7, 2018 | ||||||
| Nov 8, 2017 | ||||||
| Aug 9, 2017 | ||||||
| May 10, 2017 | ||||||
| Mar 21, 2017 | ||||||
| Nov 10, 2016 | ||||||
| Aug 10, 2016 | ||||||
| May 10, 2016 | ||||||
| Mar 8, 2016 | ||||||
| Nov 5, 2015 | ||||||
| Aug 13, 2015 | ||||||